FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131303665> ?p ?o ?g. }

• W2131303665 endingPage "e002218" @default.
• W2131303665 startingPage "e002218" @default.
• W2131303665 abstract "Two novel agents, dabigatran and rivaroxaban, recently gained market authorisation for prevention of venous thromboembolism (VTE) after hip and knee arthroplasty. However, safety data of the new oral anticoagulants with a long-term use of 42 days are not available for total knee arthroplasty (TKA). Furthermore, there are no clinical trials comparing dabigatran and/or rivaroxaban with nadroparin, which is used in most Dutch departments of orthopaedic surgery. Our aim is to compare the 42-day use of dabigatran and rivaroxaban versus nadroparin after TKA in a clinical explorative pilot study by assessing the incidence of major bleeding and clinically relevant non-major bleeding using a standardised model of bleeding definitions.A randomised open-label pilot study was conducted. Patients ≥18 years and weighing more than 40 kg who were scheduled for a primary elective TKA were included. Patients were randomly assigned to three groups. Patients took either a daily oral dose of dabigatran etexilate 220 mg (n=50), 10 mg of oral rivaroxaban (n=50) or subcutaneous nadroparin 0.3 ml (n=50) for 42 days. The primary safety outcome measure was the incidence of bleeding events. Major bleeding events and clinically relevant non-major bleeding events were defined according to accepted guidelines. The secondary measures of this study were the occurrence of VTE, time until the bleeding event, compliance, duration of hospital stay, rehospitalisation, outpatient clinic visits and interventions following complications. Additionally, coagulation monitoring, knee flexion range of motion and Knee injury and Osteoarthritis Outcome Score were evaluated.The results of this trial provided insight into the validity of design for an adequately powered multicentre study investigating the safety of the new oral anticoagulants compared with nadroparin, an anticoagulant applied for prevention of VTE after knee arthroplasty in the Dutch situation.ClinicalTrials.gov: NCT01431456." @default.
• W2131303665 created "2016-06-24" @default.
• W2131303665 creator A5000795240 @default.
• W2131303665 creator A5016661256 @default.
• W2131303665 creator A5026143441 @default.
• W2131303665 creator A5045583556 @default.
• W2131303665 creator A5064349206 @default.
• W2131303665 date "2013-01-01" @default.
• W2131303665 modified "2023-09-23" @default.
• W2131303665 title "Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA): Table 1" @default.
• W2131303665 cites W1967628526 @default.
• W2131303665 cites W1968699572 @default.
• W2131303665 cites W1980669153 @default.
• W2131303665 cites W2000438765 @default.
• W2131303665 cites W2004044176 @default.
• W2131303665 cites W2010599049 @default.
• W2131303665 cites W2011120342 @default.
• W2131303665 cites W2013743867 @default.
• W2131303665 cites W2014491911 @default.
• W2131303665 cites W2036506340 @default.
• W2131303665 cites W2066701117 @default.
• W2131303665 cites W2095109832 @default.
• W2131303665 cites W2095647706 @default.
• W2131303665 cites W2098649387 @default.
• W2131303665 cites W2114848253 @default.
• W2131303665 cites W2115348966 @default.
• W2131303665 cites W2137801654 @default.
• W2131303665 cites W2140707981 @default.
• W2131303665 cites W2150567120 @default.
• W2131303665 cites W2151252098 @default.
• W2131303665 cites W2333206452 @default.
• W2131303665 cites W2441750859 @default.
• W2131303665 cites W2757596200 @default.
• W2131303665 cites W3388698 @default.
• W2131303665 cites W2124120026 @default.
• W2131303665 doi "https://doi.org/10.1136/bmjopen-2012-002218" @default.
• W2131303665 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3563127" @default.
• W2131303665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23355673" @default.
• W2131303665 hasPublicationYear "2013" @default.
• W2131303665 type Work @default.
• W2131303665 sameAs 2131303665 @default.
• W2131303665 citedByCount "6" @default.
• W2131303665 countsByYear W21313036652014 @default.
• W2131303665 countsByYear W21313036652016 @default.
• W2131303665 countsByYear W21313036652017 @default.
• W2131303665 countsByYear W21313036652021 @default.
• W2131303665 crossrefType "journal-article" @default.
• W2131303665 hasAuthorship W2131303665A5000795240 @default.
• W2131303665 hasAuthorship W2131303665A5016661256 @default.
• W2131303665 hasAuthorship W2131303665A5026143441 @default.
• W2131303665 hasAuthorship W2131303665A5045583556 @default.
• W2131303665 hasAuthorship W2131303665A5064349206 @default.
• W2131303665 hasBestOaLocation W21313036651 @default.
• W2131303665 hasConcept C126322002 @default.
• W2131303665 hasConcept C141071460 @default.
• W2131303665 hasConcept C1862650 @default.
• W2131303665 hasConcept C2776301958 @default.
• W2131303665 hasConcept C2778336525 @default.
• W2131303665 hasConcept C2778661090 @default.
• W2131303665 hasConcept C2778810321 @default.
• W2131303665 hasConcept C2779161974 @default.
• W2131303665 hasConcept C71924100 @default.
• W2131303665 hasConceptScore W2131303665C126322002 @default.
• W2131303665 hasConceptScore W2131303665C141071460 @default.
• W2131303665 hasConceptScore W2131303665C1862650 @default.
• W2131303665 hasConceptScore W2131303665C2776301958 @default.
• W2131303665 hasConceptScore W2131303665C2778336525 @default.
• W2131303665 hasConceptScore W2131303665C2778661090 @default.
• W2131303665 hasConceptScore W2131303665C2778810321 @default.
• W2131303665 hasConceptScore W2131303665C2779161974 @default.
• W2131303665 hasConceptScore W2131303665C71924100 @default.
• W2131303665 hasIssue "1" @default.
• W2131303665 hasLocation W21313036651 @default.
• W2131303665 hasLocation W21313036652 @default.
• W2131303665 hasLocation W21313036653 @default.
• W2131303665 hasLocation W21313036654 @default.
• W2131303665 hasLocation W21313036655 @default.
• W2131303665 hasOpenAccess W2131303665 @default.
• W2131303665 hasPrimaryLocation W21313036651 @default.
• W2131303665 hasRelatedWork W1568966348 @default.
• W2131303665 hasRelatedWork W2515183968 @default.
• W2131303665 hasRelatedWork W2554174230 @default.
• W2131303665 hasRelatedWork W2582505536 @default.
• W2131303665 hasRelatedWork W2603244127 @default.
• W2131303665 hasRelatedWork W2609267468 @default.
• W2131303665 hasRelatedWork W2736631472 @default.
• W2131303665 hasRelatedWork W2779906290 @default.
• W2131303665 hasRelatedWork W3118338237 @default.
• W2131303665 hasRelatedWork W1570353559 @default.
• W2131303665 hasVolume "3" @default.
• W2131303665 isParatext "false" @default.
• W2131303665 isRetracted "false" @default.
• W2131303665 magId "2131303665" @default.
• W2131303665 workType "article" @default.